Navigation Links
Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010
Date:12/17/2009

HOUSTON, Dec. 17 /PRNewswire-FirstCall/ -- John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC), today formally commented on the anticipated timeline for commercialization of its microarray-based OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development - the rights to which have been assigned exclusively to the Company by Arrayit Corporation.

Howell stated, "In response to numerous inquiries received from the medical, research and investor communities following last week's exciting news announcements, we are pleased to confirm that Arrayit Diagnostics will file for Pre-Market Approval of our early stage ovarian cancer test as an 'In Vitro Diagnostic Multivariate Index Assay' shortly after the end of this year. Notwithstanding any unexpected delays with the 510(k) review and approval process, we are optimistic that we will be in position to begin marketing the test for research purposes late in the first quarter of 2010, followed by official commercial launch to the medical diagnostics industry as early as the third quarter of 2010."

Continuing, Howell added, "With plans to market the test at a cost of approximately $350 per test kit - and presuming we achieve our predetermined time-to-market objectives, we are confident that revenue of $4-$5 million is an attainable sales goal for 2010. Moreover, given that we estimate the total market for a viable early stage ovarian cancer screening test in the U.S., Japan and Europe could collectively represent use of up to 175 million kits per year; beyond 2010, annual revenues for Arrayit Diagnostics could ultimately reach into the hundreds of millions, and perhaps even billions, of dollars."

Ovarian cancer presents with largely non-specific symptoms during its initial stages of progression, however there is currently no adequate
'/>"/>

SOURCE Arrayit Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA
2. PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services
3. Reportlinker Adds Point of Care Diagnostics
4. Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015
5. Enigma Diagnostics Expands Its US and European Executive Management Teams
6. H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics
7. Quest Diagnostics Announces Final Tender Offer Results
8. New Hair Data Validate Sharp Downward Trend in Cocaine and Methamphetamine Positivity in General U.S. Workforce, According to Quest Diagnostics Drug Testing Index(TM)
9. Quest Diagnostics to Speak at the Lazard Capital Markets 6th Annual Healthcare Conference
10. Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics
11. Quotient Biodiagnostics Receives U.S. Food & Drug Administration Clearance to Enter U.S. Transfusion Diagnostics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 ... IVF Clinic in Greece, an experienced team of ... treatment of infertility for patients around the globe. , ... with VisitandCare.com. Greece unquestionably remains a global leader in ... talented and hard-working fertility specialists in the world who ...
(Date:5/5/2015)... York, New York (PRWEB) May 05, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) filed on behalf ... complications due to their use of prescription ... in the federal multidistrict litigation underway in ... According to court documents dated May 1st, ...
(Date:5/5/2015)... Baptist Medical Center Jacksonville’s cancer program has ... the American College of Surgeons. , To earn the ... 30 Commission on Cancer quality care standards, be evaluated ... levels of excellence in the delivery of comprehensive patient-centered ... care locally at a CoC-accredited cancer center, they are ...
(Date:5/5/2015)... Atlanta, Georgia (PRWEB) May 05, 2015 ... Software of Victoria BC announced the Skedans Sensor ... The platform, for mobile and web app developers, provides ... from airborne and mobile sensors. , The Skedans Sensor ... at the intersection of the Internet of Things, Web ...
(Date:5/5/2015)... May 05, 2015 MAP Health Management, ... revenue cycle management for addiction treatment facilities, announced today ... President of Business Development. Mr. Mooney, who has more ... field, will be responsible for developing new strategic partnerships ... MAP’s core products and new initiatives. , Prior to ...
Breaking Medicine News(10 mins):Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2
... Risk highest among those who had mechanical ventilation, study finds ... from the hospital after a stay in the intensive care ... following three years, new research shows. , The risk of ... while in the ICU, according to the report published in ...
... would lower people,s quality of life, , TUESDAY, March 2 ... by kidney failure yield mixed results, depending on the severity ... on dialysis with severe anemia, according to the study, tend ... -- known as erythropoiesis-stimulating agents (ESAs) and marketed as Epogen, ...
... , Irvine, Calif., March 1, 2010 UC Irvine neurobiologists ... health and, therefore, that mental stimulation could limit the ... Using a novel visualization technique they devised to study memory, ... found that everyday forms of learning animate neuron receptors that ...
... ... ... , ... WASHINGTON , March 2 Vice Admiral ...
... ... ... , ... ...
... nanoparticle growing in popularity as a bactericidal agent has been ... University study. Tested on fathead minnows ╨ an organism ... life -- nanosilver suspended in solution proved toxic and even ... settle, the solution became several times less toxic but still ...
Cached Medicine News:Health News:Death After Discharge Rates Higher in Elderly ICU Patients 2Health News:For Some on Dialysis, Anemia Drugs Pose Risks 2Health News:For Some on Dialysis, Anemia Drugs Pose Risks 3Health News:For Some on Dialysis, Anemia Drugs Pose Risks 4Health News:Learning keeps brain healthy, UCI researchers find 2Health News:AMA Honors Vice Admiral John Mateczun, M.D., With Top Government Service Award 2Health News:AMA Honors Vice Admiral John Mateczun, M.D., With Top Government Service Award 3Health News:LG Electronics Expands Benefits of Healthcare HDTVs With New Compliance Ratings at HIMSS 2010 2Health News:LG Electronics Expands Benefits of Healthcare HDTVs With New Compliance Ratings at HIMSS 2010 3Health News:LG Electronics Expands Benefits of Healthcare HDTVs With New Compliance Ratings at HIMSS 2010 4Health News:LG Electronics Expands Benefits of Healthcare HDTVs With New Compliance Ratings at HIMSS 2010 5Health News:Popular nanoparticle causes toxicity in fish, study shows 2
(Date:5/5/2015)... 2015  Desert Valley Medical Center, named a Top 100 ... first U.S. hospital to deploy the wireless Leaf Patient Monitoring ... the duration of labor and risk of caesarian births. ... of caesarean birth is reduced in mothers who are upright ... labor are given epidurals and tend to lie in their ...
(Date:5/5/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9pthtm/home_healthcare ... Healthcare Global Market - Forecast to 2020" report ... is expected to reach more than $300+ billion growing ... home healthcare equipment market is expected to grow at ... Home healthcare is gaining a tremendous attention over hospitals ...
(Date:5/5/2015)... , May 5, 2015 Lymphatic pump treatment ... antibiotic treatment, according to a new study published in ... Researchers performed LPT on infected rats ... a popular antibiotic used to treat pneumonia. After 96 ... free compared to only 25 percent of rats who ...
Breaking Medicine Technology:Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2Lymphatic Pump Treatment Enhances Antibiotic Effectiveness for Treating Pneumonia 2
... N.Y., Jan. 9, 2012 AMRI (NASDAQ: AMRI ... entire R&D continuum, today announced that as part of its ... it is considering a restructuring of its European operations focused ... of 2012 and potential further actions at its Budapest, Hungary ...
... 2012 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... be granted a compassionate leave from all his duties ... illnesses afflicting his closest family members.  The term of ...
Cached Medicine Technology:AMRI Announces Review of Its Hungary Operation 2AMRI Announces Review of Its Hungary Operation 3Executive Changes at Ampio 2Executive Changes at Ampio 3
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
Medicine Products: